Superbolan 400 by Dragon Pharma

Dragon Pharma Original Formula

Tren E + Test E + Drosta E

Superbolan 400400 mg/ml
Composition Tren E / Test E / Drosta E
Total per ml 400 mg
Esters All Enanthate
Half-Life ~7–10 days
Carrier MCT Oil
Form Injection, 10ml
Availability: Out of stock
Wishlist

Superbolan 400 — Trenbolone, Testosterone and Drostanolone Enanthate Blend by Dragon Pharma

Superbolan 400 is Dragon Pharma's high-concentration all-enanthate triple blend at 400mg/ml — combining Trenbolone Enanthate, Testosterone Enanthate and Drostanolone Enanthate in a single 10ml MCT oil vial. The same three compounds as Cut Long 300, at a higher total concentration that reduces injection volume by 25% per equivalent weekly dose — a meaningful practical advantage at the typical advanced cutting stack weekly doses of 600-800mg total.

Also searched as: Superbolan 400, Tren E Test E Masteron E blend 400mg, triple enanthate cutting blend, Superbolan Dragon Pharma.

The All-Enanthate Rationale — Why One Ester Type Matters

The pharmacological case for an all-enanthate cutting blend is the same as for Cut Long 300 — and the rationale is worth explaining in full for users encountering this type of blend for the first time:

  • All three compounds — Trenbolone Enanthate, Testosterone Enanthate and Drostanolone Enanthate — carry the same ester and have approximately the same ~7-10 day half-life
  • Matched half-lives mean all three rise together, reach steady-state together, and clear together after the last injection. This synchronises blood levels, side effect onset/offset and PCT timing across the entire stack
  • A single twice-weekly injection covers all three compounds simultaneously — no separate injection schedules, no timing complexity. The stack behaves as a single compound pharmacokinetically despite containing three active molecules
  • PCT starts 14-21 days after the last injection — the same timing for all three components simultaneously, simplifying post-cycle management

Superbolan 400 vs Cut Long 300 — The Concentration Difference

These two blends contain the same active compounds. The meaningful differences are concentration and the implied ratio per ml:

Parameter Superbolan 400 Cut Long 300
Total concentration 400 mg/ml 300 mg/ml
Per-compound (estimated) ~133 mg/ml each 100 mg/ml each
Volume for 600mg/week 1.5 ml/week (0.75ml per injection) 2 ml/week (1ml per injection)
Volume for 800mg/week 2 ml/week (1ml per injection) 2.67 ml/week (~1.33ml per injection)
10ml vial total content 4,000 mg 3,000 mg
Esters All Enanthate All Enanthate
Twice-weekly injection Yes Yes

At 800mg/week — a common advanced cutting dose for this three-compound stack — Superbolan 400 delivers this in just 1ml per twice-weekly injection. The same dose with Cut Long 300 requires 1.33ml per injection. At higher doses (1,000mg+/week), the injection volume difference becomes more meaningful for single-site comfort. Superbolan 400 delivers more compound per ml, making it the more efficient choice when running this specific combination at doses above 600mg/week.

What Each Component Contributes

Component Estimated Amount Primary Role
Trenbolone Enanthate ~133 mg/ml Primary anabolic — lean mass, fat oxidation, strength; no aromatisation
Testosterone Enanthate ~133 mg/ml Androgenic base — hormonal wellbeing, libido support; aromatises (AI as needed)
Drostanolone Enanthate ~133 mg/ml Hardness + internal AI — SHBG binding, aromatase inhibition of Test component, dry physique

The Drostanolone (Masteron) component at 133mg/ml partially manages the estrogen from Testosterone Enanthate through its intrinsic aromatase inhibitory activity — reducing but not eliminating the need for an external AI. At higher total doses (1ml+ twice weekly), additional estrogen management from Arimidex or Aromasin may be required for the testosterone component.

Effects and Benefits

  • The complete advanced cutting stack in a single vial — Trenbolone's anabolism, testosterone's androgenic base, Masteron's hardening and internal AI
  • Higher concentration than Cut Long 300 — 25% less injection volume for equivalent weekly doses
  • All enanthate esters — synchronised twice-weekly injection schedule for all three compounds
  • No aromatisation from Trenbolone or Drostanolone — estrogen managed only from Testosterone component
  • Drostanolone's SHBG binding increases free testosterone bioavailability from the testosterone component

Dosage and Administration

Experience Level Weekly Dose Volume at 400mg/ml Frequency Cycle Length
Advanced (first use) 600 mg/week 1.5 ml/week Twice weekly (0.75ml) 10–14 weeks
Advanced high-dose 800–1,000 mg/week 2–2.5 ml/week Twice weekly (1–1.25ml) 10–12 weeks

Superbolan 400 is an advanced compound — the Trenbolone Enanthate component requires prior Trenbolone experience. Start at 600mg/week to assess response from all three compounds before escalating. Cabergoline is recommended alongside for the Trenbolone 19-nor prolactin effects. PCT begins 14-21 days after the last injection.

Side Effects

  • From Trenbolone Enanthate: insomnia, night sweats, prolactin elevation (Cabergoline recommended), cardiovascular stress
  • From Testosterone Enanthate: aromatisation — partially managed by Drostanolone's internal AI; additional Arimidex at higher doses
  • Suppression of natural testosterone — Post Cycle Therapy required; start 14-21 days after last injection

Related Products

  • Cut Long 300 — the same all-enanthate trio at 300mg/ml; lower concentration, slightly higher injection volume per dose; same pharmacological profile
  • Cut Mix 150 — the short-ester (Acetate/Propionate) version; every-other-day injection, faster clearance and earlier PCT
  • Clomid or Nolvadex for PCT

"Superbolan 400 delivers the same all-enanthate Trenbolone/Testosterone/Masteron cutting stack as Cut Long 300 at 400mg/ml — a 25% higher concentration that translates directly to smaller injection volumes at equivalent weekly doses, the key practical advantage for higher-dose protocols."

Storage and Handling

Store Superbolan 400 at room temperature away from direct sunlight and heat. Use sterile technique for every draw.

Please log in to write review.

Superbolan 400 contains Trenbolone Enanthate, Testosterone Enanthate and Drostanolone Enanthate (Masteron Enanthate) at approximately 133mg/ml each, totalling 400mg/ml. All three use the same Enanthate ester — matching their release profiles, half-lives (~7-10 days) and clearance timelines for synchronised twice-weekly dosing.

Both contain the same three compounds — Trenbolone Enanthate, Testosterone Enanthate and Drostanolone Enanthate — in the same all-enanthate format. The only meaningful difference is concentration: 400mg/ml (Superbolan) vs 300mg/ml (Cut Long 300). At 800mg/week, Superbolan 400 requires 1ml per twice-weekly injection; Cut Long 300 requires approximately 1.33ml per injection. Superbolan 400 delivers 25% more compound per ml — the practical advantage is smaller injection volumes at equivalent weekly doses.

Matched esters produce matched pharmacokinetics — all three compounds rise together, reach steady-state together and clear together after the last injection. This means a single twice-weekly injection schedule covers all three compounds, PCT timing is the same for all three (14-21 days post last injection), and side effect onset and offset are synchronised across the stack. Mixed ester blends create different pharmacokinetic curves for each compound, complicating timing.

The Drostanolone Enanthate component provides intrinsic aromatase inhibition that partially manages estrogen from the Testosterone Enanthate component. At lower doses (600mg/week — ~200mg each compound), this internal AI activity often provides sufficient estrogen control. At higher doses (800mg+/week), the increased testosterone load typically warrants additional Arimidex or Aromasin alongside.

If your weekly dose is 600mg or below, either formulation works comfortably — Cut Long 300 gives 2ml/week vs Superbolan 400's 1.5ml/week. For weekly doses of 800mg and above, Superbolan 400's higher concentration keeps injection volumes at a comfortable 1-1.25ml per twice-weekly injection — making it the practical choice for higher-dose protocols.

14-21 days after the last injection — all three components use Enanthate esters with ~7-10 day half-lives, so the same PCT timing applies to the entire blend simultaneously. This synchronised clearance is one of the practical advantages of an all-enanthate blend versus a mixed-ester stack where different compounds clear at different rates.